United States v. Syncor Taiwan, Inc. (C.D. Cal. 2002)

• Case Name
• United States v. Syncor Taiwan, Inc. (C.D. Cal. 2002)

• Date Filed
• 12/05/2002

• Enforcement Agency
• DOJ

• Countries
• Taiwan

• Foreign Official
• Physicians Employed by State-Owned Hospitals. 

• Date of Conduct
• 1997 to 2002

• Nature of Business
• Syncor Taiwan, Inc. (“Syncor Taiwan”) is a Taiwan corporation engaged in providing radio-pharmacy services and outpatient medical imaging services.  Syncor Taiwan is a wholly-owned subsidiary of Syncor International Corporation (“Syncor”), a Delaware corporation.

• Influence to be Obtained
• 1) Obtaining and retaining business from those hospitals, 2) the purchase and sale of unit dosages of certain radiopharmaceuticals, and 3) referrals of patients to medical imaging centers owned by Syncor Taiwan.

• Enforcement
• On December 3, 2003, Syncor Taiwan pleaded guilty to violating the FCPA’s anti-bribery provision and agreed to pay a $2 million fine, the maximum criminal fine for a corporation under the FCPA.  Notably, this matter was discovered in the course of due diligence in connection with the acquisition of Syncor Taiwan’s parent.

• Amount of the Value
• At least $457,117.

• Amount of Business Related to Payment
• Not Stated

• Intermediary
• None

• Total Sanction
• $ 2,000,000

• Compliance Monitor
• No

• Reporting Requirements
• No

• Case is Pending?
• No

• Total Combined Monetary Sanction
• $ 2,500,000

• Related Enforcement Actions
• SEC v. Monty Fu (D.D.C. 2007)
  SEC v. Syncor Int’l Corp. (D.D.C. 2002)
  

Syncor Taiwan, Inc. 

• Citation
• United States v. Syncor Taiwan, Inc., No. 02-cr-1244 (C.D. Cal. 2002).

• Date Filed
• 12/05/2002

• Filed Under Seal
• No

• FCPA Statutory Provision
• • Anti-Bribery

• Other Statutory Provision
• None

• Disposition
• Plea Agreement

• Defendant Jurisdictional Basis
• Territorial Jurisdiction

• Defendant's Citizenship
• Taiwan